Hypofractionated radiotherapy and adjuvant chemotherapy do not increase radiation-induced dermatitis in breast cancer patients

Current Oncology

Volumn 17, Issue 5, 2010, Pages 22-27

  Hijal, T ^a   Al Hamad, A A ^b   Niazi, T ^b   Sultanem, K ^b   Bahoric, B ^b   Vuong, T ^b   Muanza, T ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Breast cancer; Chemotherapy; Hypofractionated radiotherapy; Skin toxicity

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; NAVELBINE; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CLINICAL EVALUATION; CONTROLLED STUDY; FOLLOW UP; HUMAN; INJURY SEVERITY; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PATIENT ASSESSMENT; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RETROSPECTIVE STUDY; TREATMENT DURATION;

EID: 78149424731     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v17i5.604     Document Type: Article

References (21)

1. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-106.
2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
3. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breastconserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost eortc 22881-10882 trial. J Clin Oncol 2007;25:3259-65.
4. Romestaing P, Lehingue Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997;15:963-8.
5. Schomberg PJ, Shanahan TG, Ingle JN, et al. Accelerated hyperfractionation radiation therapy after lumpectomy and axillary lymph node dissection in patients with stage i or ii breast cancer: pilot study. Radiology 1997;202:565-9.
6. Whelan T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002;94:1143-50.
7. Whelan TJ, Kim DH, Sussman J. Clinical experience using hypofractionated radiation schedules in breast cancer. Semin Radiat Oncol 2008;18:257-64.
8. The start Trialists' Group. The U.K. Standardisation of Breast Radiotherapy (start) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet Oncol 2008;9:331-41.
9. The start Trialists' Group. The U.K. Standardisation of Breast Radiotherapy (start) Trial B of radiotherapy hypofractionation for the treatment of early breast cancer: a randomized trial. Lancet 2008;371:1098-107.
10. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
11. Fletcher GH. Hypofractionation: lessons from complications. Radiother Oncol 1991;20:10-15.
12. Gallez-Marchal D, Fayolle M, Henry-Amar M, et al. Radiation injuries of the gastrointestinal tract in Hodgkin's disease: the role of exploratory laparotomy and fractionation. Radiother Oncol 1984;2:93-9.
13. Trotti A, Colevas AD, Setser A, et al. ctcae v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-81.
14. Aaronson NK, Bartelink H, van Dongen JA, van Dam FS. Evaluation of breast conserving therapy: clinical, methodological and psychosocial perspectives. Eur J Surg Oncol 1988;14:133-40.
15. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (rtog) and the European Organization for Research and Treatment of Cancer (eortc). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
16. Yarnold J, Ashton A, Bliss J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005;75:9-17.
17. Olivotto IA, Weir LM, Kim-Sing C, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol 1996;41:7-13.
18. Ash DV, Benson EA, Sainsbury JR, Round C, Head C. Sevenyear follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the Yorkshire Breast Cancer Group. Clin Oncol 1995;7:93-6.
19. Shelley W, Brundage M, Hayter C, Paszat L, Zhou S, Mackillop W. A shorter fractionation schedule for postlumpectomy breast cancer patients. Int J Radiat Oncol Biol Phys 2000;47:1219-28.
20. Yamada Y, Ackerman I, Franssen E, MacKenzie RG, Thomas G. Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? Int J Radiat Oncol Biol Phys 1999;44:99-104.
21. Taher AN, El-Baradie MM, Essa H, Zaki O, Ezzat S. Hypofractionation versus conventional fractionation radiotherapy after conservative treatment of breast cancer: early skin reactions and cosmetic results. J Egypt Natl Canc Inst 2004;16:178-87.